Pharmacokinetics and Safety of the WHO Recommended Increased Dosages of the First-line Anti-TB Medications in Children With TB and HIV/TB Coinfection
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Isoniazid/rifampicin (Primary) ; Rifampicin/isoniazid/pyrazinamide/ethambutol (Primary)
- Indications Tuberculosis
- Focus Pharmacogenomic; Pharmacokinetics
- 11 Oct 2012 Biomarkers information updated
- 10 Oct 2012 Last checked against ClinicalTrials.gov record.
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.